Abstract
Microparticles offer various significant advantages as drug delivery systems, including: (i) an effective protection of the encapsulated active agent against (e.g. enzymatic) degradation, (ii) the possibility to accurately control the release rate of the incorporated drug over periods of hours to months, and (iii) an easy administration (compared to alternative parenteral controlled release dosage forms, such as macro-sized implants). Desired, pre-programmed drug release profiles can be provided which match the therapeutic needs of the patient. This article gives an overview on the most important past, current and future strategies using drug-loaded microparticles to improve the efficiency of various medical treatments. Special emphasis is laid on the different types of preparation techniques that are commonly used, the physicochemical properties of the devices and practical examples illustrating the considerable benefits of this type of advanced drug delivery systems. But also the major challenges and obstacles to be overcome during the development and production of these pharmaceutical dosage forms are pointed out.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
References
Tanquary AC, Lacey RE (1974) Controlled Release of Biologically Active Agents. Plenum Press, New York
Baker R (1987) Controlled Release of Biologically Active Agents. Wiley, New York
Fan LT, Singh SK (1989) Controlled release. A Quantitative Treatment. Springer, Berlin
Freitas S, Merkle HP, Gander B (2005) J Controlled Release 102:313
Berkland C, King M, Cox A, Kim K, Pack DW (2002) J Controlled Release 82:137
Sinha VR, Trehan A (2003) J Controlled Release 90:261
Okada H (1997) Adv Drug Del Rev 28:43
Okada H, Heya T, Ogawa Y, Toguchi H, Shimamoto T (1991) Pharm Res 8:584
Okada H, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H (1991) Pharm Res 8:787
Okada H, Toguchi H (1995) Crit Rev Ther Drug Carrier Syst 12:1
Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC (1994) J Natl Cancer Inst 86:431
Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N (2000) J Obstet Gynaecol Res 26:325
Benoit JP, Faisant N, Venier-Julienne MC, Menei P (2000) J Controlled Release 65:285
Menei P, Benoit JP (2003) Acta Neurochir Suppl 88:51
Menei P, Jadaud E, Faisant N, Boisdron-Celle M, Michalak S, Fournier D, Delhaye M, Benoit JP (2004) Cancer 100:405
Tatard VM, Venier-Julienne MC, Saulnier P, Prechter A, Benoit JP, Menei P, Montero-Menei CN (2005) Biomaterials 26:3727
Siepmann J, Göpferich A (2001) Adv Drug Del Rev 48:229
Faisant N, Siepmann J, Benoit JP (2002) Eur J Pharm Sci 15:355
Siepmann J, Faisant N, Benoit JP (2002) Pharm Res 19:1885
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Siepmann, J., Siepmann, F. (2006). Microparticles Used as Drug Delivery Systems. In: Richtering, W. (eds) Smart Colloidal Materials. Progress in Colloid and Polymer Science, vol 133. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-32702-9_3
Download citation
DOI: https://doi.org/10.1007/3-540-32702-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-32701-1
Online ISBN: 978-3-540-32702-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)